Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Matcha, a powdered form of specially grown green tea (Camellia sinensis), is often promoted for its antioxidant properties and overall health benefits. Scientific interest in matcha regarding mitochondrial support centers on its high concentration of catechins, especially epigallocatechin gallate (EGCG), as well as other polyphenols and bioactive compounds. In vitro and animal studies have shown that EGCG can influence mitochondrial function by reducing oxidative stress and supporting mitochondrial biogenesis and efficiency. For instance, EGCG has been observed to activate pathways such as AMPK and PGC-1α, which are involved in energy metabolism and mitochondrial health. Some research also indicates that these antioxidants may protect mitochondria from damage caused by reactive oxygen species (ROS).

However, direct clinical evidence in humans demonstrating that matcha specifically supports mitochondrial function or treats mitochondrial dysfunction is limited. Most human studies focus on green tea’s broader effects on metabolic health, cardiovascular function, and cognitive support, rather than isolated mitochondrial outcomes. Therefore, while there is a plausible scientific basis supported by preliminary research and mechanistic studies, robust human data are lacking. The current evidence justifies a moderate (2/5) rating for matcha’s use in supporting the mitochondrial system based on scientific rationale, but more clinical research is needed for conclusive claims.

More about matcha
More about Mitochondria

Other ingredients that support Mitochondria

Other body systems supported by matcha

Products containing matcha